Adherence to antipsychotics in schizophrenia

N/ACitations
Citations of this article
62Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Poor adherence to therapy is one of the main obstacles to treatment effectiveness in schizophrenia. It is the main determinant of relapse, hospitalization, symptom persistence, and poor psychosocial functioning and outcome. Adherence to treatment is affected by various factors related to the disease characteristics, to the patient him- or herself, to the treatment, and to the therapeutic relationship. Some of these factors are modifiable, and both pharmacological and non-pharmacological strategies have been developed for this purpose. This book addresses the different aspects of adherence to treatment in schizophrenia and related disorders in a systematic but easy-to-use manual format. Chapters focus on a full range of issues, including pharmacological and non-pharmacological strategies to enhance adherence and continuity of care, relevant psychological factors, the importance of the patient-doctor relationship, and the need for an alliance with other care-givers. Adherence to Antipsychotics in Schizophrenia will be an invaluable asset for all who are involved in the care of patients with schizophrenia.

Cite

CITATION STYLE

APA

Sacchetti, E., Vita, A., & Fleischhacker, W. (2014). Adherence to antipsychotics in schizophrenia. Adherence to Antipsychotics in Schizophrenia (pp. 1–159). Springer-Verlag Italia s.r.l. https://doi.org/10.1007/978-88-470-2679-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free